Imperial College / Oxford University / Cambridge University / University of East Anglia / /
IndustryTerm
cancer therapy / stage biotechnology company using non-traditional approaches / university technologies / healthcare / treatment of colorectal and other forms of cancer / energy / companies based on technologies / corporate venture capital arm / treatment of metastatic cancer / /
MedicalCondition
Cancer LONDON / tumor / cancer / nearby cancer / metastatic solid tumours / metastatic cancer / clinically unmet diseases / kill cancer / /
MedicalTreatment
cancer therapy / /
Organization
Cambridge University / Imperial College London / Lundbeck Foundation / Mercia Fund / Scientific Advisory Board / Society on Sarcopenia / Cachexia and Wasting Diseases / UCL / Oxford University / European Society for Gene and Stem Cell Therapy / University of East Anglia / /
Person
Mette Kirstine Agger / Gene Cell / Matthew Foy / Andrew Coats / Stem Cell / Michael Moore / Stefan Anker / John Beadle / Kerry Fisher / Len Seymour / Susan Searle / Erik Clausen / David Robinson / / /
Position
President / co-founder / Chief Executive Officer / Professor of Cardiology / specialist / Secretary General / Managing Partner / CEO / Chair / Chairman of the Board of Directors / Chair of Gene Medicine / internationally-recognized specialist / /
FOR IMMEDIATE RELEASE PSIOXUS THERAPEUTICS SECURES £22 MILLION ($34 MILLION) IN SERIES B FINANCING TO DRIVE CLINICAL DEVELOPMENT FOR ONCOLYTIC VACCINE Investment to Advance ColoAd1 through Phase II Clinical Trial for